Article
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus.
Biomolecules - 8 Jun 2023
Nakayamada Shingo, Tanaka Yoshiya
Abstract excerpt
The treatment of rheumatoid arthritis was revolutionized with the use of molecular-targeted drugs that target immunoregulatory molecules. The success of treatment with these drugs prompted the development of molecular-targeted drugs for systemic lupus erythematosus. However, systemic lupus erythematosus is a disease with high heterogeneous immune abnormalities, and diverse cells or molecules can be treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
